PRICES include / exclude VAT
Homepage>ASTM Standards>ASTM E2898-20A - Standard Guide for Risk-Based Validation of Analytical Methods for PAT Applications
Released: 2020-06-19

ASTM E2898-20A

Standard Guide for Risk-Based Validation of Analytical Methods for PAT Applications

Format
Availability
Price and currency
English PDF Redline
Immediate download
68.48 USD
PDF
Immediate download
57.78 USD
Hardcopy
In stock
57.78 USD
Language:English
Released:2020-06-19
Pages:7
Standards number:ASTM E2898-20A
Standard number:E2898-20A
Released:01.06.2020
Status:Active
Pages:7
Section:14.01
Keywords:at-line; in-line; in-process measurements; method development; method verification; multivariate modeling; off-line; on-line; PAT; process analytical; process analytical technology; process analytics; process analyzers; risk assessment; sampling; validation;
DESCRIPTION

1.1 This guide provides an overview to the risk-based validation of process analytical methods under a process analytical technology (PAT) paradigm for pharmaceuticals and biopharmaceuticals and as such includes guidance on assessing risk to product quality from inappropriate method validation.

1.2 This guide builds on existing standards on the topic of validation concentrating on applying such standards to analytical methods for on-line analysis. In particular, it addresses the validation of at-line, on-line, or in-line PAT measurements and covers both drug substance and drug product (DP) measurements.

1.3 The definitions of International Council for Harmonisation (ICH) validation parameters (such as specificity, precision, repeatability, etc.) apply; however, the method of demonstrating the validation parameters may vary from that described in ICH and is discussed.

1.4 As consistent with the U.S. Food and Drug Administration (FDA) process validation guidance, this document also briefly covers ongoing assurance that the method remains in a validated state during routine use.

1.5 Equipment and instrument qualification are out of the scope of this guide but will be referenced as inputs to validation of analytical methods for PAT applications.

1.6 The validation of multivariate prediction models is out of scope but will be referenced as inputs to validation of analytical methods for PAT applications.

1.6.1 The validation of any analytical model used in the PAT method is essential to the validation of the PAT method but, the details of the model validation process is out of scope. See term model validation, 3.1.7.

1.7 Microbiological methods are out of scope.

1.8 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.

1.9 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.